Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.
In the News
- May 20, 2022
- CTV News
Burnaby company granted Health Canada licence to produce ‘magic mushroom medicine’
Kevin Charach
Imperial College study on psilocybin for depression highlights need for Real-World Evidence trials
- March 15, 2022
- Microdose
Is the UK Becoming a Global Center for Psychedelic Medicine?
Freddie Earlam
- February 9, 2022
- Truffle Report
Using Real-World Evidence to Accelerate Psychedelic Drug Development
Emily Jarvie
- November 30, 2021
- Psychedelic Health
Albert Labs receives conditional approval for CSE listing
Stephanie Price
- November 29, 2021
- Benzinga
Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
Javier Hasse
Previous
Next
Industry News
- October 22, 2022
- The Lancet
The Lancet Commission on Ending Stigma and Discrimination in Mental Health
Prof Graham Thornicroft PhD, Charlene Sunkel NSC, et al.
- October 12, 2022
- PSYCH
The MHRA’s Innovation Passport
- October 10, 2022
- Monash University
The Magic Mushroom Experience: Taking Psilocybin for Science
Devon Stoliker, Adeel Razi
- September 27, 2022
- The Economist
Psychedelic Therapy could reduce Anxiety, Distress among Patients with Cancer
Alok Jha
Previous
Next